STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees sil… | HappeningNow.news
Published Date: May 30, 2026

Health STAT 1h 14m ago

STAT+: BioNTech and Pfizer tout bispecifics data, and Pazdur sees silver lining at FDA

ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.

AI Summary Powered by Happening Now AI

ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.

Read full article on Statnews

AI summaries can be wrong sometimes—always verify important details using the source article.

SUPPORT HAPPENINGNOW · Independent AI News Intelligence
SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow